Note: Ingredients listed on restricted chemical lists
EC/CAS
204-624-6/123-39-7
Name of the chemical
N-Methylformamid
Concentration
616-056-
General Information
Version
6.9
Revision date
2023-02-11
Product name
N-Methylformamide
CAS No.
123-39-7
REACH No
is
Emergency telephone
+33 (0)9 75 18 14 07 (CHEMTREC
Icons in SDS
Company Information
company name
Merck Life Science S.A.S
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H312, H360D
Hazard statements
Code
Statements
H312
Harmful in contact with skin
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H312 Harmful in contact with skin. H360D May damage the unborn child. Restricted to professional users. Reduced Labeling (<= 125 ml) H360D May damage the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Rapidly absorbed through skin.
